Setmelanotide
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Rhythm · Phase 3 · Active, not recruiting · Enrollment 143
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Setemelanotide | Obesity or overweight | n/r | 52 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 52 | n/r | n/r |
| Setmelanotide | Obesity or overweight | n/r | 52 | n/r | n/r |